Kancera Ab Stock Total Asset
| KAN Stock | SEK 1.01 0.01 0.98% |
Kancera AB fundamentals help investors to digest information that contributes to Kancera AB's financial success or failures. It also enables traders to predict the movement of Kancera Stock. The fundamental analysis module provides a way to measure Kancera AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kancera AB stock.
Kancera |
Kancera AB Company Total Asset Analysis
Kancera AB's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Kancera AB Total Asset | 133.64 M |
Most of Kancera AB's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kancera AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, Kancera AB has a Total Asset of 133.64 M. This is 98.22% lower than that of the Healthcare sector and 93.24% lower than that of the Biotechnology industry. The total asset for all Sweden stocks is 99.55% higher than that of the company.
Kancera Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kancera AB's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kancera AB could also be used in its relative valuation, which is a method of valuing Kancera AB by comparing valuation metrics of similar companies.Kancera AB is currently under evaluation in total asset category among its peers.
Kancera Fundamentals
| Return On Equity | -0.47 | |||
| Return On Asset | -0.27 | |||
| Operating Margin | (72.39) % | |||
| Current Valuation | 14.76 M | |||
| Shares Outstanding | 79.53 M | |||
| Shares Owned By Insiders | 13.72 % | |||
| Shares Owned By Institutions | 2.86 % | |||
| Price To Earning | (11.64) X | |||
| Price To Book | 1.44 X | |||
| Price To Sales | 168.19 X | |||
| Revenue | 1.7 M | |||
| Gross Profit | 1.7 M | |||
| EBITDA | (45.35 M) | |||
| Net Income | (45.69 M) | |||
| Cash And Equivalents | 106.52 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 442 K | |||
| Debt To Equity | 33.30 % | |||
| Current Ratio | 2.11 X | |||
| Book Value Per Share | 1.50 X | |||
| Cash Flow From Operations | (44.12 M) | |||
| Earnings Per Share | (0.87) X | |||
| Target Price | 1.6 | |||
| Beta | 1.28 | |||
| Market Capitalization | 262.69 M | |||
| Total Asset | 133.64 M | |||
| Working Capital | 11 M | |||
| Current Asset | 16 M | |||
| Current Liabilities | 5 M | |||
| Net Asset | 133.64 M |
About Kancera AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kancera AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kancera AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kancera AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kancera Stock Analysis
When running Kancera AB's price analysis, check to measure Kancera AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kancera AB is operating at the current time. Most of Kancera AB's value examination focuses on studying past and present price action to predict the probability of Kancera AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kancera AB's price. Additionally, you may evaluate how the addition of Kancera AB to your portfolios can decrease your overall portfolio volatility.